Patents by Inventor E. C. Henley

E. C. Henley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of reducing low density lipoprotein cholesterol concentration
    Publication number: 20040071800
    Abstract: The present invention is a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy hypocotyl material are co-administered to the human, where the plant sterol comprises at least 0.
    Type: Application
    Filed: October 20, 2003
    Publication date: April 15, 2004
    Applicant: The Solae Company, LLC.
    Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
  • Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol
    Patent number: 6669952
    Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: December 30, 2003
    Assignee: Solae, LLC
    Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
  • Administering a composition containing plant sterol, soy protein and isoflavone for reducing LDL-cholesterol
    Patent number: 6572876
    Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.
    Type: Grant
    Filed: March 22, 2001
    Date of Patent: June 3, 2003
    Assignee: Solae, LLC
    Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
  • Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
    Patent number: 6544566
    Abstract: A composition is provided comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which the plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. Also provided is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: April 8, 2003
    Assignee: Protein Technologies International, Inc.
    Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
  • Composition for and method of reducing low density lipoprotein cholesterol concentration
    Publication number: 20010029248
    Abstract: The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.
    Type: Application
    Filed: March 30, 2001
    Publication date: October 11, 2001
    Applicant: Protein Technologies International, Inc.
    Inventors: Doyle H. Waggle, Susan M. Potter, E. C. Henley
  • Composition for and method of preventing or treating breast cancer
    Patent number: 6300367
    Abstract: The present invention is a composition for preventing, minimizing, or reversing the development or growth of breast cancer. The composition contains a combination of a selective estrogen receptor modulator selected from at least one of raloxifene, droloxifene, toremifene, 4′-iodotamoxifen, and idoxifene and at least one isoflavone selected from genistein, daidzein, biochanin A, formononetin, and their respective naturally occurring glucosides and glucoside conjugates. The present invention also provides a method of preventing, minimizng, or reversing the development or growth of breast cancer in which a selective estrogen receptor modulator selected from at least one of raloxifene, droloxifene, toremifene, 4′-iodotamoxifen, and idoxifene is co-administered with at least one isoflavone selected from genistein, daidzein, biochanin A, formononetin, and their naturally occuring glucosides and glucoside conjugates to a woman having or predisposed to having breast cancer.
    Type: Grant
    Filed: April 20, 1999
    Date of Patent: October 9, 2001
    Assignee: Protein Technologies International, Inc.
    Inventors: Richard B. Taylor, E. C. Henley